Following antigen engagement of the T-cell receptor (TCR), T-cell surv
ival is largely dictated by the provision of additional signals, such
as those from costimulatory receptors and cytokine receptors. Whilst C
D28-mediated signalling is increasingly associated with survival, liga
tion of alternative T-cell antigens, such as Fas (CD95), can trigger a
poptosis. The T-cell response following antigen engagement may therefo
re be influenced by the relative expression levels of these coreceptor
s as well as by the availability of their ligands (CD80/86 and Fas-L).
In this study we demonstrate functional interplay between the death r
eceptor Fas and the costimulatory receptor CD28 in human T cells. In J
urkat T cells, we show that Fas signalling leads to rapid and selectiv
e CD28 down-regulation, and that this is associated with a specific de
crease in mRNA for CD28, indicating that mechanisms exist which target
CD28 at a transcriptional level. Moreover, cells that down-regulate C
D28 also undergo apoptosis. Studies on activated human peripheral bloo
d T cells demonstrate that cells expressing high levels of CD28 are re
sistant to Fas-mediated apoptosis whereas cells expressing low levels
are more susceptible, implicating CD28 in the provision of anti-apopto
tic signals. Consistent with this hypothesis, direct ligation of CD28
using B7 transfectants concomitant with anti-Fas challenge protects fr
om apoptosis. Since antigen-presenting cells may express Fas-L under c
ertain circumstances, the maintenance of T-cell CD28 expression may be
crucial for the prevention of Fas-mediated apoptosis during the cours
e of antigen engagement.